Bisphosphonate therapy in fibrous dysplasia

Clinical Orthopaedics and Related Research

Volumn 382, Issue , 2001, Pages 6-12

  Lane, Joseph M ^a,b   Khan, Safdar N ^b   O'Connor, William J ^b   Nydick, Martin ^a   Hommen, Jan Pieter ^b   Schneider, Robert ^a   Tomin, Emre ^b   Brand, Jordan ^b   Curtin, Janet ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; ETIDRONIC ACID; PAMIDRONIC ACID; PEPTIDE DERIVATIVE; RISEDRONIC ACID; TILUDRONIC ACID;

ADULT; BONE RADIOGRAPHY; BONE TURNOVER; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG EFFECT; FEMALE; FIBROUS DYSPLASIA; HUMAN; MALE; PAIN ASSESSMENT; PATHOLOGIC FRACTURE; PRIORITY JOURNAL;

EID: 0035167714     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-200101000-00003     Document Type: Conference Paper

References (16)

1. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females
2. Effects of calcitonin in Paget's disease and polyostotic fibrous dysplasia
3. Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia
4. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone
5. Monostotic fibrous dysplasia
6. Osteoporosis
7. Fibrous dysplasia of bone
8. Long term effects of intravenous pamidronate in fibrous dysplasia of bone
9. Polyostotic fibrous dysplasia with contrasting responses to calcitonin and mithramycin: Aetiological and therapeutic implications
10. Increased interleukin-6 production in mouse osteoblastic MC3T3-E1 cells expressing activating mutant of the stimulatory G protein
11. Effect of pamidronate on clinical symptoms and bone metabolism in fibrous dysplasia and McCune-Albright syndrome
12. Severe endocrine and nonendocrine manifestations of the Mc-Cune-Albright syndrome associated with activating mutations of stimulatory G protein GS
13. The molecular basis of disorders caused by defects in G proteins
14. Fibrous dysplasia. An analysis of options for treatment
15. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome
16. Increased IL6 production by cells isolated from the fibrous bone dysplasia tissues in patients with Mc-Cune-Albright syndrome